Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Enliven Therapeutics, Inc. (ELVN)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
29 Feb 2024
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
1,805
-86%
12,000
$16.42
$197,006.30
SELL
27 Feb 2024
Hohl Benjamin
CHIEF FINANCIAL OFFICER, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
3,250
$16.97
$55,162.90
SELL
15 Feb 2024
Heyman Richard A.
Director
Enliven Therapeutics, Inc.
(ELVN)
144,740
-0%
1,270
$17.42
$22,117.43
SELL
14 Feb 2024
5AM Partners VI, LLC
10% Owner
Enliven Therapeutics, Inc.
(ELVN)
3,200,634
-20%
825,000
$14.90
$12,292,500.00
SELL
6 Feb 2024
Patel Anish
CHIEF OPERATING OFFICER, Officer
Enliven Therapeutics, Inc.
(ELVN)
12,347
-28%
4,875
$15.11
$73,658.32
SELL
31 Jan 2024
5AM Partners VI, LLC
10% Owner
Enliven Therapeutics, Inc.
(ELVN)
3,888,992
-11%
500,000
$15.00
$7,500,000.00
SELL
30 Jan 2024
Heyman Richard A.
Director
Enliven Therapeutics, Inc.
(ELVN)
146,010
-0%
1,270
$16.41
$20,839.56
SELL
29 Jan 2024
Hohl Benjamin
CHIEF FINANCIAL OFFICER, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
3,250
$15.81
$51,388.35
SELL
29 Jan 2024
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
12,000
$15.85
$190,256.40
SELL
25 Jan 2024
Kintz Samuel
President and CEO, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
9,458
-55%
12,000
$15.69
$188,229.50
SELL
22 Jan 2024
Patel Anish
Chief Operating Officer, Officer
Enliven Therapeutics, Inc.
(ELVN)
17,222
-22%
4,875
$15.14
$73,783.13
SELL
29 Dec 2023
Lyssikatos Joseph P
Chief Scientific Officer, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
2,849
-80%
12,000
$14.28
$171,381.28
SELL
28 Dec 2023
Hohl Benjamin
Chief Financial Officer, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
11,870
$15.02
$178,326.88
SELL
28 Dec 2023
Patel Anish
Chief Operating Officer, Officer
Enliven Therapeutics, Inc.
(ELVN)
22,097
-37%
13,540
$15.02
$203,348.34
SELL
26 Dec 2023
Kintz Samuel
President and CEO, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
12,000
$14.64
$175,708.80
SELL
22 Dec 2023
Patel Anish
Chief Operating Officer, Officer
Enliven Therapeutics, Inc.
(ELVN)
35,637
-2%
1,085
$15.03
$16,306.28
SELL
22 Dec 2023
Hohl Benjamin
Chief Financial Officer, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
1,130
$15.07
$17,024.98
SELL
21 Dec 2023
Heyman Richard A.
Director
Enliven Therapeutics, Inc.
(ELVN)
147,280
-0%
216
$13.00
$2,808.00
SELL
21 Dec 2023
Lyssikatos Joseph P
Chief Scientific Officer, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
6,566
$13.07
$85,790.04
SELL
21 Dec 2023
Kintz Samuel
President and CEO, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
8,195
$13.05
$106,915.14
SELL
20 Dec 2023
Kintz Samuel
President and CEO, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
7,779
$13.01
$101,238.24
SELL
19 Dec 2023
Lyssikatos Joseph P
Chief Scientific Officer, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
8,888
$13.01
$115,645.65
SELL
19 Dec 2023
Heyman Richard A.
Director
Enliven Therapeutics, Inc.
(ELVN)
147,455
-2%
4,280
$13.02
$55,727.05
SELL
3 Nov 2023
Lyssikatos Joseph P
Chief Scientific Officer, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
8,546
$13.08
$111,750.91
SELL
3 Nov 2023
Kintz Samuel
President and CEO, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
8,026
$13.08
$104,999.34
SELL
25 Sep 2023
Kintz Samuel
President and CEO, Director, Officer
Enliven Therapeutics, Inc.
(ELVN)
0
-100%
12,000
$13.81
$165,691.20
SELL
24 Aug 2023
5AM Partners VI, LLC
10% Owner
Enliven Therapeutics, Inc.
(ELVN)
4,470,968
-8%
440,000
$16.00
$7,040,000.00
BUY
23 Feb 2023
COMMODORE CAPITAL LP
10% Owner
Enliven Therapeutics, Inc.
(ELVN)
718,749
+0%
621.75
$22.07
$13,723.27
SELL
22 Feb 2023
Ballal Rahul D.
Chief Executive Officer, Officer
IMARA Inc.
(IMRA)
87,835
-27%
32,861
$4.66
$153,132.25
SELL
22 Feb 2023
GRAY MICHAEL
CFO & COO, Officer
IMARA Inc.
(IMRA)
27,610
-26%
9,856
$4.67
$46,027.52
BUY
21 Feb 2023
COMMODORE CAPITAL LP
10% Owner
IMARA Inc.
(IMRA)
2,872,513
+1%
31,759
$5.15
$163,498.16
SELL
30 Jan 2023
Ballal Rahul D.
Chief Executive Officer, Officer
IMARA Inc.
(IMRA)
120,696
-8%
11,313
$3.91
$44,233.83
SELL
30 Jan 2023
GRAY MICHAEL
CFO & COO, Officer
IMARA Inc.
(IMRA)
37,466
-8%
3,596
$3.92
$14,096.32
SELL
3 Jan 2023
Leonard Braden Michael
10% Owner
IMARA Inc.
(IMRA)
1,767,774
-41%
1,250,000
$4.00
$5,000,000.00
BUY
3 Jan 2023
RA CAPITAL MANAGEMENT, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,880,021
+19%
629,297
$4.00
$2,516,055.20
SELL
3 Jan 2023
Leonard Braden Michael
10% Owner
IMARA Inc.
(IMRA)
1,767,774
-41%
1,250,000
$4.00
$5,000,000.00
SELL
30 Dec 2022
Leonard Braden Michael
10% Owner
IMARA Inc.
(IMRA)
230,000
-8%
20,000
$4.04
$80,800.00
SELL
28 Dec 2022
Leonard Braden Michael
10% Owner
IMARA Inc.
(IMRA)
250,000
-7%
20,000
$4.04
$80,800.00
SELL
22 Dec 2022
Leonard Braden Michael
10% Owner
IMARA Inc.
(IMRA)
270,000
-15%
50,000
$4.06
$203,000.00
BUY
8 Dec 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,250,724
+0%
29,899
$3.87
$115,595.07
BUY
20 Oct 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,220,825
+2%
85,902
$3.92
$336,811.50
BUY
17 Oct 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,134,923
+19%
506,197
$3.68
$1,860,961.40
BUY
16 Jun 2022
Leonard Braden Michael
10% Owner
IMARA Inc.
(IMRA)
3,017,774
+2%
83,199
$1.11
$92,242.73
BUY
3 Jun 2022
Leonard Braden Michael
10% Owner
IMARA Inc.
(IMRA)
2,934,575
+1%
33,430
$1.14
$38,027.28
BUY
16 May 2022
Leonard Braden Michael
10% Owner
IMARA Inc.
(IMRA)
2,901,145
+1%
41,145
$1.23
$50,412.51
BUY
21 Apr 2022
Leonard Braden Michael
10% Owner
IMARA Inc.
(IMRA)
2,860,000
+24%
560,000
$1.40
$783,840.00
SELL
5 Apr 2022
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
2,611,050
-21%
694,551
$1.08
$751,255.75
BUY
18 Feb 2022
MOTT DAVID M
Director
IMARA Inc.
(IMRA)
229,224
+194%
151,472
$1.45
$219,667.12
BUY
15 Feb 2022
MOTT DAVID M
Director
IMARA Inc.
(IMRA)
77,752
+144%
45,926
$1.19
$54,673.35
BUY
10 Feb 2022
MOTT DAVID M
Director
IMARA Inc.
(IMRA)
31,826
+100%
31,826
$1.23
$39,246.16
SELL
21 Jan 2022
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,305,601
-3%
134,558
$1.50
$202,208.88
SELL
18 Jan 2022
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,440,159
-0%
26,555
$1.83
$48,725.97
SELL
12 Jan 2022
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,466,714
-0%
21,550
$1.94
$41,826.49
SELL
7 Jan 2022
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,488,264
-0%
18,760
$2.07
$38,739.78
SELL
4 Jan 2022
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,507,024
-0%
31,916
$2.26
$72,188.58
SELL
30 Dec 2021
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,538,940
-3%
116,476
$2.29
$266,870.50
SELL
27 Dec 2021
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,655,416
-1%
67,427
$2.37
$159,499.83
SELL
9 Dec 2021
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
3,722,843
-7%
291,152
$2.36
$688,499.20
BUY
16 Jul 2021
ORBIMED ADVISORS LLC
Director, 10% Owner
IMARA Inc.
(IMRA)
1,666,666
+100%
1,666,666
$6.00
$9,999,996.00
BUY
16 Jul 2021
Bonita David P
Director, 10% Owner
IMARA Inc.
(IMRA)
1,666,666
+100%
1,666,666
$6.00
$9,999,996.00
BUY
16 Jul 2021
Chin Mark
Director
IMARA Inc.
(IMRA)
2,344,072
+131%
1,333,333
$6.00
$7,999,998.00
SELL
17 Dec 2020
Ballal Rahul D.
Chief Executive Officer, Officer
IMARA Inc.
(IMRA)
0
-100%
4,999
$25.00
$124,975.00
SELL
14 Dec 2020
Ballal Rahul D.
Chief Executive Officer, Officer
IMARA Inc.
(IMRA)
0
-100%
1
$25.00
$25.00
SELL
11 Dec 2020
GRAY MICHAEL
CFO & COO, Officer
IMARA Inc.
(IMRA)
0
-100%
1,250
$25.00
$31,250.00
BUY
16 Mar 2020
New Enterprise Associates 14, L.P.
10% Owner
IMARA Inc.
(IMRA)
4,013,995
+13%
475,000
$16.00
$7,600,000.00
BUY
16 Mar 2020
PFIZER INC
10% Owner
IMARA Inc.
(IMRA)
1,481,719
+26%
312,500
$16.00
$5,000,000.00
BUY
16 Mar 2020
Rock Springs Capital Management LP
10% Owner
IMARA Inc.
(IMRA)
523,411
+91%
250,000
$16.00
$4,000,000.00
BUY
16 Mar 2020
RA CAPITAL MANAGEMENT, L.P.
10% Owner
IMARA Inc.
(IMRA)
1,454,348
+75%
625,000
$16.00
$10,000,000.00
BUY
16 Mar 2020
Arix Bioscience plc
10% Owner
IMARA Inc.
(IMRA)
1,554,558
+13%
187,500
$16.00
$3,000,000.00
BUY
16 Mar 2020
Agger Mette Kirstine
Director, 10% Owner
IMARA Inc.
(IMRA)
1,432,722
+15%
187,500
$16.00
$3,000,000.00
BUY
16 Mar 2020
Dalton Barbara
Director, 10% Owner
IMARA Inc.
(IMRA)
1,557,722
+25%
312,500
$16.00
$5,000,000.00
BUY
16 Mar 2020
Chin Mark
Director, 10% Owner
IMARA Inc.
(IMRA)
1,554,558
+13%
187,500
$16.00
$3,000,000.00
BUY
16 Mar 2020
Lundbeckfond Invest A/S
10% Owner
IMARA Inc.
(IMRA)
1,432,722
+15%
187,500
$16.00
$3,000,000.00
BUY
12 Mar 2020
ORBIMED ADVISORS LLC
Director, 10% Owner
IMARA Inc.
(IMRA)
937,500
+100%
937,500
$16.00
$15,000,000.00
BUY
12 Mar 2020
Bonita David P
Director, 10% Owner
IMARA Inc.
(IMRA)
937,500
+100%
937,500
$16.00
$15,000,000.00
Home